#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13376	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2282	707.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1849	1849	T	862	T	861	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13376	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2282	707.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1583	1583	C	861	C	861	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13376	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2282	707.0	0	HET	.	.	.	A263G,C,T	.	263	263	A	662	662	A	720	A,G,C,T	363,353,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22734	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3990	709.0	0	.	n	.	0	C265T	SNP	265	265	C	828	828	T	841	T,C,A	836,2,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22734	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3990	709.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1900	1900	A	923	A,G,C	921,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22734	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3990	709.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2534	2534	C	869	C,T	867,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22734	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3990	709.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2608	2608	A	827	A,G,C	823,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22734	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3990	709.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3160	3160	C	841	C,T	840,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	51146	blaTEM	861	861	100.0	blaTEM.l6.c4.ctg.1	2023	3147.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2024	folP	855	855	100.0	folP.l15.c4.ctg.1	2101	119.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1327	1329	AGC	205;205;206	A,G,C;G;C,T	203,1,1;205;204,2	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4426	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3730	147.4	1	SNP	p	S91F	0	.	.	271	273	TCC	753	755	TCC	157;158;158	T;C;C	157;158;158	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4426	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3730	147.4	1	SNP	p	D95N	0	.	.	283	285	GAC	765	767	GAC	162;163;161	G;A;C,T	162;163;160,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4426	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3730	147.4	1	SNP	p	D95G	0	.	.	283	285	GAC	765	767	GAC	162;163;161	G;A;C,T	162;163;160,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1854	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1827	126.4	0	.	p	.	0	A39T	NONSYN	115	117	GCC	625	627	ACC	194;195;195	A,G,C;C;C	192,1,1;195;195	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1854	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1827	126.4	0	.	p	.	0	L47P	NONSYN	139	141	CTC	649	651	CCC	197;202;204	C;C,T;C	197;201,1;204	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1854	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1827	126.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	823	825	CAC	262;262;261	C,T;A,G;C	261,1;261,1;261	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1854	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1827	126.4	1	SNP	p	G45D	0	.	.	133	135	GGC	643	645	GGC	196;197;200	G;G,C;C,T	196;196,1;199,1	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1026	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1605	79.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4474	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3489	159.6	1	SNP	p	D86N	0	.	.	256	258	GAC	911	913	GAC	194;193;191	G;A,G;C	194;192,1;191	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4474	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3489	159.6	1	SNP	p	S87R	0	.	.	259	261	AGT	914	916	AGT	190;191;191	A;G;T	190;191;191	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4474	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3489	159.6	1	SNP	p	S87I	0	.	.	259	261	AGT	914	916	AGT	190;191;191	A;G;T	190;191;191	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4474	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3489	159.6	1	SNP	p	S87W	0	.	.	259	261	AGT	914	916	AGT	190;191;191	A;G;T	190;191;191	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4474	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3489	159.6	1	SNP	p	S88P	0	.	.	262	264	TCC	917	919	TCC	192;190;188	T;C,T;C	192;189,1;188	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4112	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3238	158.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1880	1882	GGC	242;243;245	G,A;G,T;C	241,1;242,1;245	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3750	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	160.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1500	1502	GCA	191;190;194	G;C,G;A,G	191;189,1;193,1	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3750	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	160.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1503	1505	ATC	193;194;194	A;T;CAAA,CAA	193;194;181,1	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3750	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	160.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1515	1517	GTG	197;198;198	G;T;G	197;198;198	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3750	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	160.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1515	1517	GTG	197;198;198	G;T;G	197;198;198	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3750	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	160.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2019	2021	ACC	189;188;187	A,T;C,T;C,A	188,1;187,1;186,1	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3750	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	160.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2073	2075	GCG	185;186;184	G,A;C;G,A	184,1;186;183,1	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3750	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	160.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2073	2075	GCG	185;186;184	G,A;C;G,A	184,1;186;183,1	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3750	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	160.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2196	2198	GGC	216;217;218	G;G;C,A	216;217;217,1	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3750	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	160.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2205	2207	GGC	216;217;216	G,T;G,C;C,T	215,1;216,1;215,1	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3750	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	160.7	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2223	2225	TCG	217;215;218	T,G;C,G;G,C	216,1;214,1;217,1	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5408	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3675	183.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1964	1966	CCG	215;217;217	C,T;C,T,A;G	214,1;215,1,1;217	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2318	porA	1146	1146	99.65	porA.l15.c30.ctg.1	2452	117.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	864	864	C	188	C	188	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	100	94.0	porB1a.l15.c4.ctg.4	182	48.1	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	65;63;59	A;C,A;G	65;62,1;59	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	100	94.0	porB1a.l15.c4.ctg.4	182	48.1	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	17;16;14	C;A;A	17;16;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	34	36	AAT	14;14;14	A;A;T	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	37	39	AAT	14;14;14	A;A;T	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	61	63	GCA	14;14;14	G;C;A	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	84	86	GTA	14;14;14	G;T;A	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	S236N	NONSYN	706	708	AGC	90	92	AAC	15;15;15	A;A;C	15;15;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	.	MULTIPLE	709	711	AAC	94	98	TGGCG	15;15;15;15;15	T;G;G;C;G	15;15;15;15;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	D238A	NONSYN	712	714	GAT	100	102	GCT	15;15;15	G;C;T	15;15;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	A251V	NONSYN	751	753	GCG	139	141	GTA	26;23;23	G;T;A	26;23;23	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	S271T	NONSYN	811	813	TCG	199	201	ACT	77;77;77	A;C;T	76;76;76	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	205	207	GAT	77;77;77	G;A;T	76;76;76	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	D276N	NONSYN	826	828	GAT	214	216	AAC	76;76;76	A;A;C	76;76;76	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	318	porB1a	984	295	90.3	porB1a.l15.c4.ctg.5	304	37.4	0	.	p	.	0	N277H	NONSYN	829	831	AAC	217	219	CAC	76;76;76	C;A;C	76;76;76	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	2928	porB1b	1041	1041	100.0	porB1b.l15.c17.ctg.1	2135	171.0	1	SNP	p	G120K	1	.	.	358	360	AAG	933	935	AAG	244;244;246	A;A;G	244;244;246	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	2928	porB1b	1041	1041	100.0	porB1b.l15.c17.ctg.1	2135	171.0	1	SNP	p	D121N	0	.	.	361	363	GAC	936	938	GAC	243;245;248	G;A,G;C,T	243;244,1;247,1	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	27	2928	porB1b	1041	1041	100.0	porB1b.l15.c17.ctg.1	2135	171.0	1	SNP	p	A121D	1	.	.	361	363	GAC	936	938	GAC	243;245;248	G;A,G;C,T	243;244,1;247,1	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9194	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	5489	208.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2283	2285	CAT	246;244;245	C;A;T	246;244;245	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1306	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1498	108.7	1	SNP	p	V57M	1	.	.	169	171	ATG	778	780	ATG	240;239;236	A;T,C;G,A	240;238,1;235,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
